HomePGO • FRA
add
Prostatype Genomics AB
Previous close
€0.0030
Day range
€0.0024 - €0.0030
Year range
€0.0024 - €0.12
Market cap
27.12M SEK
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.64M | 439.01% |
Operating expense | 6.80M | 55.60% |
Net income | -11.77M | -44.26% |
Net profit margin | -717.55 | 73.24% |
Earnings per share | — | — |
EBITDA | -10.23M | -33.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.68M | -76.66% |
Total assets | 49.22M | 59.04% |
Total liabilities | 24.55M | 411.50% |
Total equity | 24.67M | — |
Shares outstanding | 119.46M | — |
Price to book | 0.01 | — |
Return on assets | -54.34% | — |
Return on capital | -108.10% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -11.77M | -44.26% |
Cash from operations | -4.40M | 43.95% |
Cash from investing | -4.32M | — |
Cash from financing | 4.22M | 4,315.98% |
Net change in cash | -4.51M | 43.31% |
Free cash flow | -10.97M | -128.94% |
About
Founded
2007
Website
Employees
5